Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice

Gynecologic Oncology

Volumn 121, Issue 2, 2011, Pages 309-313

  Kinney, Walter ^a   Fetterman, Barbara ^b   Cox, J Thomas ^c   Lorey, Thomas ^b   Flanagan, Tracy ^a   Castle, Philip E ^d,e  

^a KAISER PERMANENTE   (United States)

^b Regional Laboratory   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e American Society for Clinical Pathology   (United States)

Author keywords

Cervical cancer; Cytology; HPV testing; Human papillomavirus (HPV)

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER INVASION; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL PRACTICE; CYTOLOGY; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; PAPANICOLAOU TEST; PELVIC NODE DISSECTION; PRIORITY JOURNAL; SMALL CELL CARCINOMA; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX ADENOSQUAMOUS CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX SMALL CELL CARCINOMA; WART VIRUS;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 79955467421     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.361     Document Type: Article

References (43)

1. H.C. Kitchener, P.E. Castle, and J.T. Cox Chapter 7: achievements and limitations of cervical cytology screening Vaccine 24 Suppl 3 2006 S63 S70 S63-70
2. J. Cuzick, C. Clavel, K.U. Petry, C.J. Meijer, H. Hoyer, and S. Ratnam Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 2006 1095 1101 (Pubitemid 44116919)
3. S.S. Wang, M.E. Sherman, A. Hildesheim, J.V. Lacey Jr., and S. Devesa Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 Cancer 100 2004 1035 1044 (Pubitemid 38232621)
4. H.O. Smith, M.F. Tiffany, C.R. Qualls, and C.R. Key The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study Gynecol Oncol 78 2000 97 105 (Pubitemid 30650338)
5. L.L. Reimers, W.F. Anderson, P.S. Rosenberg, D.E. Henson, and P.E. Castle Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models Cancer Epidemiol Biomarkers Prev 18 2009 792 800
6. S.C. Plaxe, and S.L. Saltzstein Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening Gynecol Oncol 75 1999 55 61 (Pubitemid 29477802)
7. X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, and S. Franceschi Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention J Natl Cancer Inst 98 2006 303 315 (Pubitemid 43338210)
8. J.S. Smith, L. Lindsay, B. Hoots, J. Keys, S. Franceschi, and R. Winer Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update Int J Cancer 121 2007 621 632 (Pubitemid 46986496)
9. P.E. Castle, C.M. Wheeler, D. Solomon, M. Schiffman, and C.L. Peyton Interlaboratory reliability of Hybrid Capture 2 Am J Clin Pathol 122 2004 238 245 (Pubitemid 38971357)
10. F.M. Carozzi, A. Del Mistro, M. Confortini, C. Sani, D. Puliti, and R. Trevisan Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting Am J Clin Pathol 124 2005 716 721
11. M. Arbyn, P. Sasieni, C.J. Meijer, C. Clavel, G. Koliopoulos, and J. Dillner Chapter 9: clinical applications of HPV testing: A summary of meta-analyses Vaccine 24 Suppl 3 2006 S78 S89
12. N.W. Bulkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J. Boeke, and S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 2007 1764 1772 (Pubitemid 350137476)
13. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues, S.D. Walter, J. Hanley, and A. Ferenczy Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588 (Pubitemid 47598400)
14. P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, and K. Elfgren Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597 (Pubitemid 47598401)
15. A. Anttila, L. Kotaniemi-Talonen, M. Leinonen, M. Hakama, P. Laurila, and J. Tarkkanen Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme BMJ 340 2010 c1804 10.1136/bmj.c1804
16. G. Ronco, P. Giorgi-Rossi, F. Carozzi, M. Confortini, P.D. Palma, and M.A. Del Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol 2010
17. T.C. Wright Jr., M. Schiffman, D. Solomon, J.T. Cox, F. Garcia, and S. Goldie Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Obstet Gynecol 103 2004 304 309
18. D.G. Ferris, J.T. Cox, D.M. O'Connor, C.V. Wright, and J. Foerster Modern Colposcopy 2004 Kendall Hunt Publishing Company Dubuque, Iowa 329 349
19. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
20. H.Y. Sung, K.A. Kearney, M. Miller, W. Kinney, G.F. Sawaya, and R.A. Hiatt Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan Cancer 88 2000 2283 2289 (Pubitemid 30247128)
21. M. Arbyn, M. Kyrgiou, C. Simoens, A.O. Raifu, G. Koliopoulos, and P. Martin-Hirsch Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis BMJ 337 2008 a1284 10.1136/bmj.a1284
22. P.E. Castle, B. Fetterman, N. Poitras, T. Lorey, R. Shaber, and W. Kinney Five-year experience of human papillomavirus DNA and papanicolaou test cotesting Obstet Gynecol 113 2009 595 600
23. M. Arbyn, C. Bergeron, P. Klinkhamer, P. Martin-Hirsch, A.G. Siebers, and J. Bulten Liquid compared with conventional cervical cytology: a systematic review and meta-analysis Obstet Gynecol 111 2008 167 177
24. A.G. Siebers, P.J. Klinkhamer, J.M. Grefte, L.F. Massuger, J.E. Vedder, and A. Beijers-Broos Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial JAMA 302 2009 1757 1764
25. G. Ronco, J. Cuzick, P. Pierotti, M.P. Cariaggi, P.P. Dalla, and C. Naldoni Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial BMJ 335 2007 28
26. G.F. Sawaya Evidence-based medicine versus liquid-based cytology Obstet Gynecol 111 2008 2 3
27. M.H. Stoler, and M. Schiffman Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study JAMA 285 2001 1500 1505 (Pubitemid 32221899)
28. M.E. Sherman, A. Dasgupta, M. Schiffman, R. Nayar, and D. Solomon The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology Cancer 111 2007 15 25 (Pubitemid 46281080)
29. M.E. Sherman, A.T. Lorincz, D.R. Scott, S. Wacholder, P.E. Castle, and A.G. Glass Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis J Natl Cancer Inst 95 2003 46 52 (Pubitemid 36124295)
30. H.C. Kitchener, M. Almonte, C. Thomson, P. Wheeler, A. Sargent, and B. Stoykova HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial Lancet Oncol 10 2009 672 682
31. P. Sasieni, P.E. Castle, and J. Cuzick Further analysis of the ARTISTIC trial Lancet Oncol 10 2009 841 842
32. F. Carozzi, M. Confortini, P.D. Palma, M.A. Del, A. Gillio-Tos, and M.L. De Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial Lancet Oncol 2008
33. A. Szarewski, L. Ambroisine, L. Cadman, J. Austin, L. Ho, and G. Terry Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomark Prev 17 2008 3033 3042
34. M.J. Khan, P.E. Castle, A.T. Lorincz, S. Wacholder, M. Sherman, and D.R. Scott The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice J Natl Cancer Inst 20 97 2005 072 079
35. Y. Tanaka, S. Sawada, and T. Murata Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix Acta Radiol Oncol 23 1984 455 459 (Pubitemid 15073560)
36. D.G. Morton, L.D. Lagasse, R.D. Moore, M. Jacobs, and G.D. Amromin Pelvic lymphnodectomy following radiation in cervical carcinoma Am J Obstet Gynecol 88 1964 932 943
37. J.B. Graham, L.S.J. Sotto, and F.P. Paoloucek Carcinoma of the Cervix 1962 WB Saunders Philadelphia 190
38. A. Christensen, P. Lange, and E. Nielsen Surgery and radiotherapy for invasive cancer of the cervix. Surgical treatment Acta Obstet Gynecol Scand 43 Suppl 2 1964 59 87
39. S.C. Pak, M. Martens, R. Bekkers, A.J. Crandon, R. Land, and J.L. Nicklin Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix Aust N Z J Obstet Gynaecol 47 2007 504 507 (Pubitemid 350075929)
40. P. Sasieni, A. Castanon, and J. Cuzick Screening and adenocarcinoma of the cervix Int J Cancer 125 2009 525 529
41. F. Bray, B. Carstensen, H. Moller, M. Zappa, M.P. Zakelj, and G. Lawrence Incidence trends of adenocarcinoma of the cervix in 13 European countries Cancer Epidemiol Biomark Prev 14 2005 2191 2199 (Pubitemid 41603267)
42. R.G. Pretorius, W.H. Zhang, J.L. Belinson, M.N. Huang, L.Y. Wu, and X. Zhang Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse Am J Obstet Gynecol 191 2004 430 434 (Pubitemid 39178694)
43. D. Solomon, M. Stoler, J. Jeronimo, M. Khan, P. Castle, and M. Schiffman Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities Obstet Gynecol 110 2007 288 295 (Pubitemid 47356652)